Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Silvestro Volpe"'
Autor:
Giovanni D’Arena, Alessandro Sgambato, Silvestro Volpe, Giuseppe Coppola, Rachele Amodeo, Virginia Tirino, Fiorella D’Auria, Teodora Statuto, Luciana Valvano, Giuseppe Pietrantuono, Silvia Deaglio, Dimitar Efremov, Luca Laurenti, Antonella Aiello
Publikováno v:
Hematological Oncology. 40:835-842
Measurable residual disease (MRD) has emerged as a relevant parameter of response to therapy in chronic lymphocytic leukemia (CLL). Although several methods have been developed, flow cytometry has emerged as the most useful and standardized approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b444d5c321179ce14546cdb64fcc376b
https://doi.org/10.1002/hon.3037
https://doi.org/10.1002/hon.3037
Autor:
Luca Laurenti, Giordano Annamaria, Antonella Aiello, Giovanni D'Arena, Virginia Tirino, Pellegrino Musto, Giuseppe Pietrantuono, Silvestro Volpe, Fiorella D'Auria, Rachele Amodeo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd491d26b873c752e1aa3a70fddc6fc7
https://hdl.handle.net/11591/482074
https://hdl.handle.net/11591/482074
Autor:
Agostino Ippolito, Giorgio Fassina, Angela Scarallo, Maria Marino, Menotti Ruvo, Silvestro Volpe
Publikováno v:
Molecular Immunology. 37:951-960
The encephalitogenic epitope P81–100 from mouse myelin basic protein was used to generate two simplified derivatives with glycine substitutions in alternating positions which were tested for their biological activity in a murine model of multiple s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e807cf5900533d98f71160645a53ca3c
https://doi.org/10.1016/s0161-5890(01)00016-5
https://doi.org/10.1016/s0161-5890(01)00016-5
Autor:
Patrizia, Maio, Sebastiano, Leone, Silvestro, Volpe, Giuseppina, dell'Aquila, Sergio, Giglio, Mario, Magliocca, Francesco Saverio, Nigro, Piera, Pacifico, Nicola, Acone
Publikováno v:
The new microbiologica. 32(2)
Visceral Leishmaniasis (VL) is a vector-borne zoonosis endemic in Southern Italy whose usual clinical features include fever, splenomegaly, pancytopenia and hypergammaglobulinemia. The clinical and biochemical picture may be misleading in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0cc21f06ad5da80d30054918d18875c
https://pubmed.ncbi.nlm.nih.gov/19579705
https://pubmed.ncbi.nlm.nih.gov/19579705
Autor:
Paola Tacchetti, Patrizia Tosi, Michele Cavo, Annamaria Brioli, Delia Cangini, Giuliana Leopardi, Elena Zamagni, Alessandro Gozzetti, Antonio Ledda, Francesco Casulli, Nicoletta Testoni, Massimo Offidani, Carolina Terragna, Affra Carubelli, Alessandro Petrucci, Lucia Pantani, Claudia Cellini, Michele Baccarani, Silvestro Volpe, Giulia Perrone, Chiara Nicci, Luciano Masini, Francesco Di Raimondo, Michela Ceccolini, Catello Califano, Francesca Patriarca, Lucio Catalano, Mauro Fiacchini
Publikováno v:
ResearcherID
Abstract 349 We report here on the final analysis of the multicenter phase II “Bologna 2002” study which incorporated thal-dex into double ASCT with high-dose melphalan (200 mg/m2) as front-line therapy for younger patients with symptomatic multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa59c7796c3e930643ae76ba1f60e3d
http://hdl.handle.net/20.500.11769/75921
http://hdl.handle.net/20.500.11769/75921
Autor:
Massimo Offidani, Mauro Fiacchini, Patrizia Tosi, Catia Bigazzi, Piero Maria Stefani, Paola Tacchetti, Elena Zamagni, Antonio De Vivo, Silvestro Volpe, Antonio Ledda, Francesca Patriarca, Giulia Perrone, Francesco Di Raimondo, Antonio Francesco Casulli, Michele Baccarani, Catello Califano, Michela Ceccolini, Filippo Ballerini, Michele Cavo, Annamaria Brioli
Purpose To assess potential benefits with thalidomide incorporated into double autologous stem-cell transplantation (ASCT) for younger patients with newly diagnosed multiple myeloma (MM). Patients and Methods One hundred thirty-five patients who rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db58bdd5250c690a73d0d7900826d4a5
http://hdl.handle.net/20.500.11769/55503
http://hdl.handle.net/20.500.11769/55503
Autor:
Antonio Ledda, Piero Galieni, Francesco Di Raimondo, Franco Narni, Alessandro Gozzetti, Annalisa Pezzi, Antonio Lazzaro, Luciano Masini, Michele Baccarani, Lucio Catalano, Mauro Fiacchini, Nicoletta Testoni, Francesca Patriarca, Carolina Terragna, Katia Mancuso, Sonia Ronconi, Michele Cavo, Annamaria Brioli, Catello Califano, Paola Tacchetti, Silvestro Volpe, Beatrice Anna Zannetti, Elena Zamagni, Emanuele Angelucci, Claudia Cellini, Patrizia Tosi, Lucia Pantani
Publikováno v:
Blood. 120:594-594
Abstract 594 Survival of patients with multiple myeloma (MM) has been extended with the introduction of autologous stem cell transplantation (ASCT). More recently, availability of highly effective novel agents has further improved patient outcomes. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7b623d651e15a4ff1cfc6b1447874e8
https://doi.org/10.1182/blood.v120.21.594.594
https://doi.org/10.1182/blood.v120.21.594.594
Autor:
Giuseppe Avvisati, Giuliana Leopardi, Luca De Rosa, Michele Baccarani, Silvana Capalbo, Silvestro Volpe, Immacolata Attolico, Silvana Pasini, Alessandro Gozzetti, Antonio Capaldi, Giulia Perrone, Elena Zamagni, Giuseppe Mele, Patrizia Pregno, Alessandro Moscetti, Anna Mele, Vittorio Fregoni, Fausto Rossini, Ernesto Vigna, Michele Magni, Giuseppe Nunziata, Monica Crugnola, Luigi Podda, Sergio Amadori, Anna Marina Liberati, Michele Cavo, Annamaria Brioli, Giuliana Farina
Publikováno v:
ResearcherID
Abstract 317 Introduction: The novel agents bortezomib, thalidomide and lenalidomide have been successfully incorporated into autologous stem-cell transplantation (ASCT) as up-front therapy for newly diagnosed MM. However, several reports have raised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b5be02292faef7aa6225660a93728a
https://doi.org/10.1182/blood.v118.21.317.317
https://doi.org/10.1182/blood.v118.21.317.317
Autor:
Piero Maria Stefani, Affra Carubelli, Michela Ceccolini, Sadia Falcioni, Claudia Cellini, Alessandro Gozzetti, Lucio Catalano, Patrizia Tosi, Francesca Patriarca, MC Pallotti, Matteo Renzulli, Michele Baccarani, Nicoletta Testoni, Giulia Perrone, Francesco Casulli, Carolina Terragna, Antonio Ledda, Francesco Di Raimondo, Lucia Pantani, Luciano Masini, Paola Tacchetti, Elena Zamagni, Mauro Fiacchini, Silvestro Volpe, Catello Califano, Chiara Nicci, Michele Cavo, Annamaria Brioli
Publikováno v:
ResearcherID
The phase II “Bologna 2002” clinical study incorporated thalidomide-dexamethasone (thal-dex) into double ASCT with melphalan (200 mg/m2) as frontline therapy for patients with symptomatic multiple myeloma (MM) and less than 65 years of age. By st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d67ce81b8a681800848dc2680f56dd
https://doi.org/10.1182/blood.v110.11.447.447
https://doi.org/10.1182/blood.v110.11.447.447
Autor:
Lelia Valdrè, Michela Ceccolini, Antonio Ledda, Affra Carubelli, Claudia Cellini, Michele Cavo, Annamaria Brioli, MC Pallotti, Giulia Perrone, Cristina Legnani, Lucio Catalano, Elisa Favaretto, Paola Tacchetti, Sadia Falcioni, Francesco Casulli, Alessandro Gozzetti, Francesca Patriarca, Michele Baccarani, Elena Zamagni, Luciano Masini, Catello Califano, Patrizia Tosi, Lucia Pantani, Gualtiero Palareti, Michela Cini, Silvestro Volpe
Publikováno v:
ResearcherID
Venous thromboembolism (VTE) has emerged as a major adverse event of primary induction therapy with thalidomide (thal) and dexamethasone (dex) for newly diagnosed multiple myeloma (MM). Aim of the present study was to investigate the relationship bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f48eb698cae8ebc697c0b84eaf9256
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000251101100253&KeyUID=WOS:000251101100253
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000251101100253&KeyUID=WOS:000251101100253